Skip to main content

Table 2 Correlation between plasma miRNA-195 expression and different clinicopathological features in patients with non-small cell lung cancer

From: RETRACTED ARTICLE: Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer

Clinicopathological features No. of cases Plasma miR-195 expression P
Low (n, %) High (n, %)
Age
 <60 49 22(44.0 %) 27(66.0 %) 0.322
 ≥60 51 28(54.9 %) 23(45.1 %)  
Gender
 Male 65 34(52.3 %) 31(47.7 %) 0.338
 Female 35 16(45.7 %) 19(54.3 %)  
Histological type
 Squamous cell carcinoma 46 25(54.3 %) 21(45.7 %) 0.701
 Adenocarcinoma 44 20(45.5 %) 24(54.5 %)  
 Others 10 5(50.0 %) 5(50.0 %)  
Histological grade
 G1 + G2 55 26(47.3 %) 29(52.7 %) 0.688
 G3 45 24(53.3 %) 21(46.7 %)  
Tumor size
 ≤3 cm 38 16(42.1 %) 22(57.9 %) 0.151
 >3 cm 62 34(54.8 %) 28(45.2 %)  
N classification
 Positive 63 39(61.9 %) 24(28.1 %) 0.002
 Negative 37 11(29.7 %) 26(70.3 %)  
TNM stage
 I + II 57 17(29.8 %) 40(70.2 %) <0.001
 III 43 33(76.7 %) 10(23.3 %)